Among p53 proteoforms, p53γ, Δ40p53β, Δ40p53γ, Δ133p53γ, and Δ160p53γ showed significantly higher differential seroreactivity in CRC patients and colorectal premalignant individuals compared with healthy individuals. This evidence concerns the gene TP53 and colorectal carcinoma.